Express News | Cantor Fitzgerald Reiterates Overweight on Agios Pharmaceuticalsto Overweight

BenzingaDec 18 08:57 ET

The European Commission Has Adopted A Positive Decision For The Designation Of Agios Pharmaceuticals' Mitapivat As An Orphan Medicinal Product For Sickle Cell Disease

BenzingaDec 18 07:03 ET

European Commission Adopts Positive Decision for Orphan Medicinal Product Designation of Agios' Mitapivat in Sickle Cell Disease

GlobeNewswireDec 18 07:00 ET

Tesla, Micron, Broadcom, MARA Holdings And Other Big Stocks Moving Higher On Monday

BenzingaDec 16 12:33 ET

Here's Why Agios Stock Plummeted More Than 20% on Monday

Zacks Dec 10 10:00 ET

Scotiabank Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating, Maintains Target Price $75

Moomoo NewsDec 10 08:31 ET · Ratings